Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Bechstein

Showing results (301-310 of 351) with videos related to

Pageof 36
Sort By:
Clinical Transplantation|February 29, 2000
Administration of prostacyclin after liver transplantation: a placebo controlled randomized trialU P Neumann, U Kaisers, J M Langrehr, et al.
Transplantation|January 15, 1995
Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experienceP Neuhaus, G Blumhardt, W O Bechstein, et al.
Transplantation Proceedings|September 2, 1998
Synergistic mechanisms of alloantigen-dependent and independent events in chronic graft rejectionS G Tullius, M Nieminen, Y Qun, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Prompt treatment of initial acute rejection episodes may improve long-term graft outcomeS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|December 1, 1996
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantationS Jonas, W O Bechstein, N Rayes, et al.
Transplantation Proceedings|June 24, 1998
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantationJ M Langrehr, A Schneller, O Guckelberger, et al.
Zeitschrift Fur Arztliche Fortbildung|April 1, 1994
[Living with a liver transplant--indications, prognosis and quality of life]J M Langrehr, H Keck, W O Bechstein, et al.
Clinical Transplantation|December 31, 1997
Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled studyJ M Langrehr, A Kahl, M Meyer, et al.
Transplantation Proceedings|March 27, 2001
Donor pretreatment of grafts from marginal donors improves long-term graft outcomeA Reutzel-Selke, S G Tullius, T Zschockelt, et al.
Transplantation Proceedings|March 27, 2001
Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1S G Tullius, M Nieminen-Kelhä, A Reutzel-Selke, et al.
Pageof 36

Showing results (301-310 of 351) with videos related to

Sort By:
Pageof 36
Clinical Transplantation|February 29, 2000
Administration of prostacyclin after liver transplantation: a placebo controlled randomized trialU P Neumann, U Kaisers, J M Langrehr, et al.
Transplantation|January 15, 1995
Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experienceP Neuhaus, G Blumhardt, W O Bechstein, et al.
Transplantation Proceedings|September 2, 1998
Synergistic mechanisms of alloantigen-dependent and independent events in chronic graft rejectionS G Tullius, M Nieminen, Y Qun, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Prompt treatment of initial acute rejection episodes may improve long-term graft outcomeS G Tullius, M Nieminen, W O Bechstein, et al.
Transplantation Proceedings|December 1, 1996
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantationS Jonas, W O Bechstein, N Rayes, et al.
Transplantation Proceedings|June 24, 1998
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantationJ M Langrehr, A Schneller, O Guckelberger, et al.
Zeitschrift Fur Arztliche Fortbildung|April 1, 1994
[Living with a liver transplant--indications, prognosis and quality of life]J M Langrehr, H Keck, W O Bechstein, et al.
Clinical Transplantation|December 31, 1997
Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled studyJ M Langrehr, A Kahl, M Meyer, et al.
Transplantation Proceedings|March 27, 2001
Donor pretreatment of grafts from marginal donors improves long-term graft outcomeA Reutzel-Selke, S G Tullius, T Zschockelt, et al.
Transplantation Proceedings|March 27, 2001
Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1S G Tullius, M Nieminen-Kelhä, A Reutzel-Selke, et al.
Pageof 36